Low Pressure Pneumoperitoneum
ProcedureLowering intra-abdominal pressure during laparoscopic surgery
Other names: Low intra-abdominal pressure
NCT Number: NCT03608436
Randomised controlled trial comparing the effect of low pressure pneumoperitoneum with deep neuromuscular block versus normal pressure pneumoperitoneum with moderate neuromuscular block during laparoscopic colorectal surgery on early quality of recovery.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Canisius Wilhelmina Hospital, Nijmegen, Gelderland, Netherlands
Rationale: the laparoscopic approach reduced trauma as compared to open surgery, however, the pressure used to create a PNP with sufficient surgical workspace still leads to significant tissue injury. Prior studies show that the use of low-pressure pneumoperitoneum (PNP) during laparoscopic surgery reduced postoperative pain scores, cumulative opioid consumption and improved bowel function recovery. Deep neuromuscular blockade (NMB) as compared to moderate NMB decreases the amount of intra-abdominal pressure required to achieve similar surgical conditions and enables the use of low-pressure PNP without compromising the quality of the surgical field and patient safety. Therefore, the use of deep NMB with low-pressure PNP could be a significant addition to the conventional Enhanced Recovery After Surgery (ERAS) protocols.
Objective: to establish the relationship between the use of low pressure pneumoperitoneum with deep neuromuscular blockade and the early quality of recovery after laparoscopic colorectal surgery.
Study design: a multi-center, blinded, randomized controlled clinical trial.
Study population: adult individuals scheduled for laparoscopic colorectal surgery with a primary colonic anastomosis.
Intervention: participants will be randomly assigned in a 1:1 fashion to either the experimental group (group A): low pressure PNP (8 mmHg) with deep NMB (PTC 1-2) or the control group (group B): normal pressure PNP (12 mmHg) with moderate NMB (TOF count 1-2).
Primary endpoint: Quality of recovery score (QoR-40) 24 hours after surgery.
Secondary endpoints: QoR-40 score (day 3 and 7 after surgery), McGill pain- and RAND-36 score (1 day before and 3 months after surgery), pain scores, PONV, analgesia use, length of hospital stay, postoperative complications, surgical conditions and time to reach discharge criteria.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Lowering intra-abdominal pressure during laparoscopic surgery
Other names: Low intra-abdominal pressure
Deep (PTC 1-2) versus moderate (Tof count 1-2) neuromuscular block
Other names: Deep muscle relaxation
Time frame: 24 hours after surgery
The QoR-40 is a validated assessment tool for measuring a patient's self-assessed quality of recovery after surgery. It consists of 40 questions measuring 5 dimensions: patient support, comfort, emotions, physical independence and pain. Each item is rated on a scale of 1 to 5, giving a minimal score of 40 and a maximum score of 200.
Time frame: Day 3 and day 7 after surgery
The QoR-40 is a validated assessment tool for measuring a patient's self-assessed quality of recovery after surgery. It consists of 40 questions measuring 5 dimensions: patient support, comfort, emotions, physical independence and pain. Each item is rated on a scale of 1 to 5, giving a minimal score of 40 and a maximum score of 200.
Time frame: Upon admission and 3 months after surgery
Validated questionnaire for the assessment of quality and intensity of pain
Time frame: Upon admission and 3 months after surgery
Validated patient-reported survey of health
Time frame: 1, 8, 24, and 72 hours after surgery
Pain at rest and pain upon movement (NRS 0-10), is pain acceptable yes or no, referred shoulder pain yes or no?
Time frame: 1, 8, 24 and 72 hours after surgery
NRS 0-10
Time frame: 1, 8, 24 and 72 hours after surgery
Total dose of opiates, other analgesics and anti-emetic drugs
Time frame: From date of admission until date of discharge from the hospital (usually several days), assessed up to 3 months.
Total number of days from admission to discharge after surgery (not including readmission)
Time frame: Intraoperative: after introduction of the trocars and every 15 minutes until the end of the pneumoperitoneum.
Rating of the surgical conditions with the Leiden Surgical Rating Scale (L-SRS). The L-SRS is scored by the surgeon and ranges from 1-5 for quality of the surgical field. A score of 5 means optimal conditions: a wide laparoscopic field with no patient movements or muscle contractions, 1 means extremely poor conditions: the surgeon is unable to obtain a visible laparoscopic field because of inadequate muscle relaxation.
Time frame: During surgery
Complications during surgery graded according to the Clavien-Dindo classification
Time frame: Up to 3 months after surgery
Postoperative complications
Time frame: From date of surgery until date of actual discharge from the hospital (usually several days), assessed up to 3 months.
Number of days to reach the following criteria after surgery: adequate pain control with oral medication, passage of flatus or defecation, intake of solid food tolerated, patient is mobilized and independent and patient accepts discharge.
Radboud University Medical Center
Other
RECOVER Study: the Effect of Low- Versus Normal Pressure Pneumoperitoneum During Laparoscopic Colorectal Surgery on the Early Quality of Recovery With Perioperative Care According to the Enhanced Recovery Principles
Acronym: RECOVER
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03572413
Digestive System Diseases, Immune Suppression
Nijmegen, Gelderland, Netherlands
View Trial DetailsNCT04468698
Digestive System Diseases, Intra Abdominal Pressure
Valencia, Spain
View Trial DetailsNCT02079337
Digestive System Diseases, Laparoscopy
Søborg, Denmark
View Trial DetailsNCT07438132
Digestive System Diseases, Laparoscopic Surgery
Taipei, Taiwan
View Trial Details